Could a simple mineral cut the need for powerful blood-pressure drugs in septic shock?

NCT ID NCT07716956

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This trial investigates whether keeping magnesium levels in the upper normal range can lower the amount and duration of norepinephrine, a drug that raises blood pressure, in adults with septic shock. Participants are randomly assigned to receive individualized magnesium infusions or standard care. Researchers will track total norepinephrine use, ICU stay length, breathing-tube duration, and survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
intravenous magnesium sulfate infusions to achieve upper normal serum magnesium levels
What this could lead to
If it works, this could point toward a simple, low-cost way to reduce the amount of blood-pressure medication needed in septic shock, potentially shortening ICU stays.
What could go wrong
This is a small, early-stage trial with only 60 participants, so results may not apply broadly. The intervention may not lower medication needs or improve survival, and magnesium infusions carry risks like low blood pressure or heart rhythm issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Alexandria Main University Hospital

    Alexandria, Alexandria Governorate, 21526, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.